NASDAQ: SONNSonnet Biotherapeutics Holdings Inc Stock Ownership - Who owns Sonnet Biotherapeutics Holdings?
Insider buying vs selling
Have Sonnet Biotherapeutics Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when SONN insiders and whales buy or sell their stock.
SONN Shareholders
What type of owners hold Sonnet Biotherapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pantera Capital Partners LP | 302.44% | 20,427,696 | $25.74M | Institution |
| Heights Capital Management Inc | 44.42% | 3,000,000 | $3.78M | Institution |
| Michael D. Pruitt | 41.99% | 2,835,998 | $3.57M | Insider |
| Larry Spitcaufsky | 14.75% | 996,258 | $1.26M | Insider |
| Ics Opportunities Ltd | 3.29% | 222,222 | $280.00k | Insider |
| John Markey | 2.76% | 186,430 | $234.90k | Insider |
| Ikarian Capital LLC | 2.22% | 150,000 | $189.00k | Institution |
| Vanguard Group Inc | 1.43% | 96,382 | $121.44k | Institution |
| Hrt Financial LP | 1.10% | 74,265 | $93.57k | Institution |
| Geode Capital Management LLC | 0.92% | 61,840 | $77.92k | Institution |
SONN vs Biotech Stocks
Sonnet Biotherapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.